摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-甲氧基苯甲酰基)-L-脯氨酸 | 62522-92-3

中文名称
1-(4-甲氧基苯甲酰基)-L-脯氨酸
中文别名
——
英文名称
(4-methoxybenzoyl)-L-proline
英文别名
N-(4-Methoxybenzoyl)-L-proline;(2S)-1-(4-methoxybenzoyl)pyrrolidine-2-carboxylic acid
1-(4-甲氧基苯甲酰基)-L-脯氨酸化学式
CAS
62522-92-3
化学式
C13H15NO4
mdl
MFCD09757467
分子量
249.266
InChiKey
XWAWBHSLAXRYRN-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    477.6±40.0 °C(Predicted)
  • 密度:
    1.291±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.384
  • 拓扑面积:
    66.8
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933990090

SDS

SDS:8761ec2152f46e56e604a9e10b898002
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-甲氧基苯甲酰基)-L-脯氨酸吡啶盐酸4-二甲氨基吡啶 作用下, 以 1,4-二氧六环 为溶剂, 反应 34.0h, 生成 1-butoxyethyl 3-[2-(4-methoxyphenyl)-5-trifluoromethyloxazol-4-yl]propyl ether
    参考文献:
    名称:
    A General Method for the Preparation of 5-Trifluoromethylated Oxazoles from .ALPHA.-Amino Acids.
    摘要:
    在吡啶存在下,N-酰基-N-苄基-α-氨基酸(1)或N-酰基脯氨酸(5)与三氟乙酸酐反应,以良好产率得到5-三氟甲基噁唑(2或7)。该反应可能通过形成暂态的介离子1,3-噁唑-5-醇盐,随后形成噁唑盐盐类而进行。
    DOI:
    10.1248/cpb.46.749
  • 作为产物:
    参考文献:
    名称:
    Electronic Effect of Prolinate Ligand-Dirhodium(II) Complexes on Catalytic Asymmetric Dipolar Cycloaddition
    摘要:
    DOI:
    10.3987/com-97-s54
点击查看最新优质反应信息

文献信息

  • Asymmetric Reactions Catalyzed by Chiral Metal Complexes. LXX. Steric and Electronic Effects of Substrates and Rhodium Chiral Catalysts in Asymmetric Cyclopropanation.
    作者:Kiyoshi YOSHIKAWA、Kazuo ACHIWA
    DOI:10.1248/cpb.43.2048
    日期:——
    We have prepared several new, efficient, chiral N-acyl pyrrolidine carboxylic acid ligands for dirhodium-catalyzed asymmetric cyclopropanation and found that the steric and electronic effects of the rhodium(II) complexes and substrates influenced the enantioselectivity and catalytic activity. These electron-rich catalysts were shown to be efficient for asymmetric cyclopropanation using 1-chloro-1-fluoroethylene as a substrate.
    我们已经为双铑催化的不对称环丙烷化反应准备了数种新型高效的手性N-酰基吡咯啶羧酸配体,并发现铑(II)络合物和底物的立体和电子效应会影响对映选择性和催化活性。这些富电子催化剂在以1-氯-1-氟乙烯为底物的非对称环丙烷化反应中表现出高效性。
  • Nitrogen-containing heterocyclic compound and use thereof
    申请人:Ikeura Yoshinori
    公开号:US20090156572A1
    公开(公告)日:2009-06-18
    The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B is an aromatic ring optionally having substituent(s), ring C is a cyclic group optionally having substituent(s), R 1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group, a heterocyclic group optionally having substituent(s) or an amino group optionally having substituent(s), R 2 is an optionally halogenated C 1-6 alkyl group, m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof and the like. Since the compound has a superior tachykinin receptor antagonistic action, and is useful as an agent for the prophylaxis or treatment of various diseases such as lower urinary tract diseases, gastrointestinal diseases, central nervous system diseases and the like.
    本发明涉及一种由下式表示的化合物:其中环A是含氮杂环,可选择地进一步具有取代基,环B是芳香环,可选择地具有取代基,环C是环状基团,可选择地具有取代基,R1是氢原子,一个碳氢基团,可选择地具有取代基,酰基,一个杂环基团,可选择地具有取代基或一个氨基团,可选择地具有取代基,R2是可选择卤代的C1-6烷基基团,m和n分别是0到5的整数,m+n是2到5的整数,是单键或双键,或其盐等。由于该化合物具有优越的催吐肽受体拮抗作用,可用作预防或治疗多种疾病的药物,如下尿道疾病、胃肠道疾病、中枢神经系统疾病等。
  • Palladium-Catalyzed Aminocarbonylation in Solid-Phase Peptide Synthesis: A Method for Capping, Cyclization, and Isotope Labeling
    作者:Anna Skogh、Stig D. Friis、Troels Skrydstrup、Anja Sandström
    DOI:10.1021/acs.orglett.7b01068
    日期:2017.6.2
    A new synthetic approach for introducing N-capping groups onto peptides attached to a solid support, combining aminocarbonylation under mild conditions using a palladacycle precatalyst and solid-phase peptide synthesis, is reported. The use of a silacarboxylic acid as an in situ CO-releasing molecule allowed the reaction to be performed in a single vial. The method also enables versatile substitution
    报道了一种新的合成方法,该方法用于在结合有固相支持物的肽上引入N封端基团,并在适度条件下使用Palladacycle预催化剂和固相肽合成方法将氨基羰基化结合在一起。使用硅烷羧酸作为原位释放CO的分子使得反应可以在单个小瓶中进行。该方法还可以实现侧链的通用取代,侧链至侧链的环化以及修饰肽的选择性[ 13 C]酰基标记。
  • Modified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agents
    作者:E. D. Nicolaides、F. J. Tinney、J. S. Kaltenbronn、J. T. Repine、D. A. DeJohn、E. A. Lunney、W. H. Roark
    DOI:10.1021/jm00156a012
    日期:1986.6
    A number of peptides and modified peptides were synthesized and studied for their ability to reverse electroconvulsive shock-induced amnesia in rodents. A few of these peptides were selected for secondary evaluation in tests of short-term memory in rats and aged rhesus monkeys. A number of the peptides and modified peptides were active in the amnesia reversal test. In selected secondary tests, however, the chosen compounds failed to show significant activity in enhancing memory. New methods for preparing methyleneamino and methyleneoxy isosteres of peptides are reported. Other modified peptides also included methylenethio, methylenesulfonyl, and ethylene isosteres in place of the normal peptide amide bond.
  • US4596819A
    申请人:——
    公开号:US4596819A
    公开(公告)日:1986-06-24
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物